User Perceptions of a Multilevel mHealth Intervention to Boost Adherence to Hydroxyurea in Sickle Cell Disease
Pediatric Blood & Cancer · 2025
DOI: 10.1002/pbc.31746 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2025. Verfasst von Christina M Abrams und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology-Oncology, Department of Pediatrics, Medical University of South Carolina, Charleston, South Carolina, USA. Hauptthemen laut MEDLINE: Hydroxyurea, Anemia, Sickle Cell, Telemedicine, Mobile Applications. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: NHLBI NIH HHS, NIMHD NIH HHS, St. Jude Children's Research Hospital.
Abstract (Originalsprache)
Background
Adherence to hydroxyurea has been low historically. The InCharge Health app demonstrates increased adherence with hydroxyurea, but engagement has not been fully investigated. This study investigated the association between InCharge Health app perceptions and app engagement among adolescents and young adults with sickle cell disease (SCD).
Methods
We obtained user perceptions of InCharge with the Mobile App Rating Scale (MARS) among participants of the “Integration of mHealth into Sickle Cell Disease Care to Increase Hydroxyurea Utilization” study. Days of app use were correlated with reported patient‐reported outcomes of interest, ease of use, the utility of features, and importance of features.
Results
Of 293 enrolled participants, 284 remained active in the study, and 206 (72.5%) completed the 24‐week MARS survey. App Interest was positively correlated with app use ( p = 0.01) and self‐reported days of app use ( p = 0.0008). Perceived ease of use trended toward significance with greater app use ( p = 0.06). Most individuals (72.0%, 144/200) agreed the app helped them remember to take hydroxyurea, with trends toward higher days of app use ( p = 0.07). Those who used the app more agreed they would continue to use it after the study ( p = 0.04). Most individuals (54.3%) reported that reminders to take their hydroxyurea were the most important app feature.
Conclusions
In this study, positive perceptions toward the application features influenced app use and intention to continue using the application. Determining features that drive application utilization can have a positive impact when an app, such as the InCharge app, is demonstrated to improve adherence with proven therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hematology-Oncology, Department of Pediatrics, Medical University of South Carolina, Charleston, South Carolina, USA.
- College of Nursing, Medical University of South Carolina, Charleston, South Carolina, USA.
- Division of Hematology, Oncology, and Stem Cell Transplant, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
- Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
- Prevention Research Center, The Brown School, Washington University, Saint Louis, Missouri, USA.
- Department of Emergency Medicine, Medical College of Georgia, Augusta, Georgia, USA.
ORCID-Profile: Christina M Abrams, Sherif M Badawy, Allison A King, Nirmish Shah, Jane S Hankins
Förderung
- NHLBI NIH HHS
- NIMHD NIH HHS
- St. Jude Children's Research Hospital
- American Society of Hematology
- National Heart, Lung, and Blood Institute
- National Institute on Minority Health and Health Disparities
Zitieren
APA
Abrams, C. M., Davila, N., Badawy, S. M., Kepper, M. M., Gibson, R. W., King, A. A., Gordeuk, V. R., Nwosu, C., Li, S., Glassberg, J. A., Klesges, L. M., Shah, N., Brambilla, D., Hankins, J. S., & Sickle Cell Disease Implementation Consortium (2025). User Perceptions of a Multilevel mHealth Intervention to Boost Adherence to Hydroxyurea in Sickle Cell Disease. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31746
Vancouver
Abrams CM, Davila N, Badawy SM, Kepper MM, Gibson RW, King AA, et al. User Perceptions of a Multilevel mHealth Intervention to Boost Adherence to Hydroxyurea in Sickle Cell Disease. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.31746
BibTeX
@article{Abrams2025,
author = {Abrams, Christina M and Davila, Natalia and Badawy, Sherif M and Kepper, Maura M and Gibson, Robert W and King, Allison A and Gordeuk, Victor R and Nwosu, Chinonyelum and Li, Sophi and Glassberg, Jeffrey A and Klesges, Lisa M and Shah, Nirmish and Brambilla, Don and Hankins, Jane S and Sickle Cell Disease Implementation Consortium, Sickle Cell Disease Implementation Consortium},
title = {User Perceptions of a Multilevel mHealth Intervention to Boost Adherence to Hydroxyurea in Sickle Cell Disease},
journal = {Pediatric Blood & Cancer},
year = {2025},
doi = {10.1002/pbc.31746}
}
EUVIMED